ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1359

Comparison of Sacroiliac MRI Evaluation Versus Sacroiliac x-Rays in Peripheral Psoriatic Arthritis: Evidence of Silent Disease and Lack of Association to HLA-B27

Jose Luis Fernandez-Sueiro1, JA Pinto1, S. Pertega-Diaz2, E. Gonzalez3 and Francisco J. Blanco V4, 1Rheumatology Division, Complejo Hospitalario Universitario La Coruña, La Coruña, Spain, 2Epidemiology and Statistics, Complejo Hospitalario Universitario La Coruña, La Coruña, Spain, 3Rheumatology, Complejo Hospitalario Universitario La Coruña, La Coruña, Spain, 4Rheumatology Service, INIBIC-Hospital Universitario A Coruña, A Coruña, Spain

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: human leukocyte antigens (HLA), magnetic resonance imaging (MRI) and psoriatic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondylarthropathies and Psoriatic Arthritis: Clinical Aspects and Treatment

Session Type: Abstract Submissions (ACR)

Background/Purpose: Although there are no consensus on how to define spinal involvement in axial psoriatic artritis (axPsA), our data suggest that the presence of spinal symptoms (defined as a combination of inflammatory back pain plus back stiffness) can be sufficient. However x-ray evaluation of sacroiliac joints may be normal at the first stage of the disease. Objetive: to evaluate the negative predictive value of sacroiliac x-rays versus MRI to rule out the diagnosis of sacroiliitis in peripheral PsA.

Methods: cross sectional descriptive and observational study of PsA patients classified according to CASPAR criteria. All patients had peripheral arthritis not spinal back pain and normal or grade I sacroiliac involvement determined by x-rays. All patients were evaluated according to current standard care. HLA-B27 was determined in all patients. Sacroiliac MRI was performed with either a Tesla 1.5 Gyroscan Intera (Philips MS) or Tesla 1.5 Signa-Excite with the following coronal sequences T1-TSE, T2-TGE and STIR with slices of 4mm of thickness, criteria for lesions were as ASAS proposal. The negative predictive value of x-rays versus MRI was determined as well as the 95% CI.  Patients’ characteristics were compared according to MRI results, by means of Mann-Whitney U test, chi-squared test and Fisher’s exact test.

Results: sacroiliac MRI was performed in 59 patients from a total of 97 PsA patients with peripheral arthritis. There were not significant differences in both groups of patients. MRI patients had a medium age of 49,2±12,9 years, a time of evolution of the disease of 9,4±7,6 years. 96,4% patients had a normal sacroiliac x-rays, 2 had grade I unilateral and bilateral sacroiliitis respectively. HLA-B27 was negative in 93,2%(n=55) patients. 20,3% (n=12) showed active inflammatory lesions (1 with x-rays grade I bilateral). All patients were HLA-B27 negative. There were not significant clinical differences between MRI positive/negative patients, the exception was the occiput to wall distance (p=0,032). The negative predictive value of sacroiliac x-rays versus sacroiliac MRI was of 79,7% (95%IC: 68,5%-90,8%)

Conclusion: Conventional x-rays versus MRI for the evaluation of sacroiliitis had a negative predictive value of 79,7%. In this study the sacroiliac involvement in PsA does not depend on the presence of spinal pain, HLA-B27 or radiological sacroiliitis.

*Financed with a grant from the Ministery of Health , Spain FIS PI080789


Disclosure:

J. L. Fernandez-Sueiro,
None;

J. Pinto,
None;

S. Pertega-Diaz,
None;

E. Gonzalez,
None;

F. J. Blanco V,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparison-of-sacroiliac-mri-evaluation-versus-sacroiliac-x-rays-in-peripheral-psoriatic-arthritis-evidence-of-silent-disease-and-lack-of-association-to-hla-b27/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology